Welcome to LookChem.com Sign In|Join Free
  • or
4-(6-Chloro-pyridin-3-ylMethyl)-piperazine-1-carboxylic acid tert-butyl ester, 98+% C15H22ClN3O2, MW: 311.81 is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

939986-35-3

Post Buying Request

939986-35-3 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

939986-35-3 Usage

Uses

Used in Pharmaceutical Research and Drug Development:
4-(6-Chloro-pyridin-3-ylMethyl)-piperazine-1-carboxylic acid tert-butyl ester, 98+% C15H22ClN3O2, MW: 311.81 is used as a key intermediate in the synthesis of various pharmaceutical compounds for the treatment of central nervous system disorders. Its unique chemical structure allows it to modulate specific biological targets, making it a valuable asset in the development of novel therapeutic agents.
Used in Chemical Synthesis:
In the chemical synthesis industry, 4-(6-Chloro-pyridin-3-ylMethyl)-piperazine-1-carboxylic acid tert-butyl ester, 98+% C15H22ClN3O2, MW: 311.81 serves as a versatile building block for the creation of a wide range of organic compounds. Its high purity and stable nature make it an ideal candidate for use in the synthesis of various chemical products, including pharmaceuticals, agrochemicals, and specialty chemicals.
Used in Research Applications:
4-(6-Chloro-pyridin-3-ylMethyl)-piperazine-1-carboxylic acid tert-butyl ester, 98+% C15H22ClN3O2, MW: 311.81 is also used in research applications to study the biological activity and potential therapeutic effects of compounds containing the piperazine and chloro-pyridine moieties. Researchers utilize 4-(6-Chloro-pyridin-3-ylMethyl)-piperazine-1-carboxylic acid tert-butyl ester, 98+% C15H22ClN3O2, MW: 311.81 to investigate its interactions with various biological targets and to gain insights into the development of new drugs for the treatment of central nervous system disorders.
Used in Quality Control and Standardization:
The high purity level of 98+% makes 4-(6-Chloro-pyridin-3-ylMethyl)-piperazine-1-carboxylic acid tert-butyl ester, 98+% C15H22ClN3O2, MW: 311.81 suitable for use in quality control and standardization processes within the pharmaceutical and chemical industries. It can be employed as a reference material to ensure the consistency, purity, and potency of synthesized compounds and final products.

Check Digit Verification of cas no

The CAS Registry Mumber 939986-35-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,3,9,9,8 and 6 respectively; the second part has 2 digits, 3 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 939986-35:
(8*9)+(7*3)+(6*9)+(5*9)+(4*8)+(3*6)+(2*3)+(1*5)=253
253 % 10 = 3
So 939986-35-3 is a valid CAS Registry Number.

939986-35-3SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name tert-butyl 4-[(6-chloropyridin-3-yl)methyl]piperazine-1-carboxylate

1.2 Other means of identification

Product number -
Other names tert-Butyl 4-((6-chloropyridin-3-yl)methyl)piperazine-1-carboxylate

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:939986-35-3 SDS

939986-35-3Downstream Products

939986-35-3Relevant academic research and scientific papers

DIPHENYL DERIVATIVES AND USES THEREOF

-

Paragraph 1282, (2019/03/30)

The present disclosure provides a compound of formula (I): or a pharmaceutically acceptable salt thereof, and its therapeutic uses for activating a growth factor pathway, promoting wound healing, promoting tissue repair, and treating hearing loss, skeletal muscle loss, organ degeneration, tissue damage, neurodegeneration, and muscular atrophy. The disclosure further provides pharmaceutical compositions and combinations. The present disclosure also relates to the use of such compounds for research or other non-therapeutic purposes.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 939986-35-3